Company news
Dimerix Limited (ASX:DXB) news
Dimerix Limited news releases on 6ix. Latest, Aug 27, 2018: EXECUTIVE TEAM BOLSTERED THROUGH CEO & MD APPOINTMENT
Press releases — page 4
EXECUTIVE TEAM BOLSTERED THROUGH CEO & MD APPOINTMENT
August 26, 2018
Quarterly Review & Appendix 4C
July 31, 2018
Ethics Approval Received Appendix 3B and S.708A Notice
July 18, 2018
Further US patent allowed for DMX-200
July 1, 2018
Dual Phase 2 trials launched for CKD
May 14, 2018
Westar Capital Retained as Corporate Advisors
April 12, 2018
CMO Appointment and Clinical Trials Update
March 26, 2018
Half Year Report and Financial Statements
February 26, 2018
Oversubscribed Placement to Raise a Further $4.5m
February 20, 2018
Quarterly Review and Appendix 4C
January 29, 2018
Results of Entitlement Offer
January 23, 2018
DMX-200 Dosage Optimisation Study Successfully Completed
January 7, 2018
Proteomics partnership to improve treatment of CKD
December 13, 2017
Entitlement Offer Booklet
December 5, 2017
Suspension from Official Quotation
December 4, 2017
Dimerix Phase 2a Subgroup Analysis Results
November 1, 2017
Ethics Committee Approval for Pharmacokinetic Trial
October 23, 2017
Dimerix Receives $545k R&D Tax Refund
October 17, 2017
Notice of Annual General Meeting/Proxy Form
September 12, 2017
DMX-200 tablet manufacture and human study timeline
September 4, 2017
Positive Results from Phase 2a Trial of DMX-200
July 12, 2017
Research Validates Relevance of DMX Receptor-HIT Technology
June 12, 2017
Investor Update
April 10, 2017
Receipt of $420k Research & Development Tax Refund
March 21, 2017
Corporate Presentation
February 13, 2017
Key Patent Allowed in Japan
January 30, 2017
Dimerix Raises $2 million to Advance Clinical Program
January 24, 2017
Recruitment of Part A of Phase 2 Trial of DMX-200 Completed
December 5, 2016
Appointment of Chief Executive Officer
November 6, 2016
Update presentation - interim data
October 11, 2016
Positive interim analysis of DMX-200 phase II data
October 3, 2016
Appendix 4E
August 24, 2016
Response to ASX Price and Volume Query
August 15, 2016
Outcomes of DMX-200 pre-IND meeting with the FDA
August 1, 2016
Update for NASH Pre-Clinical Program
July 28, 2016
10 Patient Milestone Reached. On Track to Report Trial Data.
June 5, 2016
ARC Linkage Grant to progress discovery platform
May 6, 2016
DXB requests US FDA pre IND meeting - performance milestone
April 27, 2016
Dimerix Receives TGA Special Access Scheme Approval
April 18, 2016
Activity Report & Appendix 4C
March 30, 2016
Receipt of US Patent Allowance for Chronic Kidney Disease
February 18, 2016
Dimerix Receives Orphan Designation
February 11, 2016
Board and Company Secretary Changes
February 10, 2016